Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies

Medical Care

Volumn 37, Issue 1, 1999, Pages 15-26

  Damiano, Anne M ^a   Patrick, Donald L ^b   Guzman, Gladys I ^a   Gawel, Marek J ^c   Gelinas, Deborah F ^d   Natter, Howard M ^e   Ingalls, Kathleen K ^f  

^a UK   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^f CEPHALON INC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Quality of life; Sickness impact profile; Validation

Indexed keywords

SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COST OF ILLNESS; DAILY LIFE ACTIVITY; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE;

ACTIVITIES OF DAILY LIVING; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; CLINICAL TRIALS; COST OF ILLNESS; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 0032603071     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199901000-00004     Document Type: Article

References (25)

1. Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luís ML. Respiratory assistance with a noninvasive ventilator (Bipap) in MND/ALS patients: Survival rates in a controlled trial. J Neurol Sci 1995;129(Suppl):19.
2. Bensimon G, Lacomblez L, Meininger V, ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585.
3. McGuire D, Garrison L, Armon C, Barohn R, Bryan W, Miller R. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. Neurology 1996;46:1442.
4. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, et al. Effect of recombinant human insulin-like growth factor I (rhIGF-I) on progression of amyotrophic lateral sclerosis: A placebo-controlled study. Neurology 1997;49:1621.
5. Schipper H, Clinch JJ, Olweny CLM. Quality of life studies: Definitions and conceptual issues. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996:11.
6. Deyo RA, Patrick DL. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989;27:S254.
7. Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: The US Food and Drug Administration Perspective. J Natl Cancer Inst 1996;20:7.
8. Bergner M, Bobbit RA, Carter QB, Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787.
9. Damiano AM. The Sickness Impact Profile User's Manual and Interpretation Guide. Baltimore, MD: The Johns Hopkins University, 1996.
10. Longstreth WT, Nelson L, Linde M, Murioz D. Utility of the Sickness Impact Profile in Parkinson's disease. J Geriatric Psychol Neurol 1992;5:142.
11. Zeldow PB, Pavlou M. Physical and psychosocial functioning in multiple sclerosis: Descriptions, correlations, and a tentative typology. Br J Med Psychol 1988;61:185.
12. Granger CV, Coter AC, Hamilton BB, Fielder RC. Functional assessment scales: A study of persons after stroke. Arch Phys Med Rehab 1993;74:133.
13. Patrick DL, Peach H, eds. Disablement in the Community. Oxford: Oxford University Press, 1989.
14. Kratz R, Felice K, Gawel M, Gelinas D, Lai EC, Lange DJ. Evaluation of the treatment effect of recombinant human insulin-like growth factor 1 on health-related quality of life in patients with amyotrophic lateral sclerosis. Neurology 1996,46:A426.
15. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience. Ann Neurol 1987;22:328.
16. Kreling B, Robinson DK, Bergner M. Data collection strategies in SUPPORT. J Clin Epidemiol 1990;43(Suppl):5S.
17. Somerville SM, Silver R, Patrick DL. Services for disabled people, what criteria should we use to assess disability? Community Med 1983;5:302.
18. Nunnally JC. Psychometric Theory, 2nd Edition. New York, NY: McGraw-Hill Book Company, 1978:245.
19. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials 1991;12:142S.
20. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population: Validation of a scoring system and a model for survival prediction. Brain 1995;118:707.
21. Tuley MR, Mulrow CD, McMahan CA. Estimating and testing an index of responsiveness and the relationship of the index to power. J Clin Epidemiol 1991;44:417.
22. Guyatt G, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171.
23. Fink A. Social dependency and self-care agency: A descriptive-correlational study of ALS patients. Master of Nursing Thesis, University of Washington, 1985.
24. Cassard SD, Patrick DL, Damiano AM, Legro MW, Tielsch JW, Diener-West M, et al. Reproducibility and responsiveness of the VF-14: An index of functional impairment in patients with cataract. Arch Ophthalmol 1995;113:1508.
25. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993;2:221.